iShares MSCI Singapore ETF vs Herbalife Nutrition Ltd — how do they compare? iShares MSCI Singapore ETF trades at $31.72 (market cap $1.49B), while Herbalife Nutrition Ltd trades at $13.03 (market cap $1.34B). The key difference: iShares MSCI Singapore ETF and Herbalife Nutrition Ltd are close in size by market cap, and iShares MSCI Singapore ETF is trading nearer its 52-week high, Herbalife Nutrition Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Singapore ETF for 45 Days and Herbalife Nutrition Ltd for 43 Days on average.
| EWS | HLF | |
|---|---|---|
Market Cap | $1.49B | $1.34B |
Volume | 2,142,305 | 1,589,457 |
Sector | Broad Market / Factor | Consumer Staples |
52-Week High | $34.57 | $19.96 |
52-Week Low | $26.71 | $7.75 |
Typical Hold Time | 45 Days | 43 Days |
Enterprise Value | — | $3.18B |
Signals from Pluang's Aura AI — not financial advice
EWS (iShares MSCI Singapore ETF) trades at $31.60, down 2.71% with bearish technical signals from moving averages and oscillators. The ETF recently hit 52-week highs amid Singapore's strong economic growth and AI momentum, attracting institutional interest including Amundi's 4.8% position increase. Key support sits at $31 with resistance at $32.
Outlook remains mixed with technical weakness offset by positive fundamental drivers. Investment opportunity lies in Singapore's economic resilience and AI-driven growth, though stretched valuations and bearish momentum present near-term risks. The ETF offers exposure to Asia's outperformance versus S&P 500 but faces volatility from regional economic sensitivity.
Herbalife (HLF) trades at $13.03, up 3.0% with a bullish technical signal. The stock shows attractive valuation metrics with P/E of 8.22 and P/S of 0.26, while maintaining strong gross margins of 77.7%. Recent Q1 2026 earnings beat expectations, though Q2 2026 missed. The company announced a $250 million share repurchase program and CEO transition, with management reaffirming 2026 guidance. Cash flow trends show improvement with projected positive net cash flow of $50 million for 2026.
HLF presents a value opportunity with discounted valuation and improving debt profile, though execution risks remain. Analyst consensus targets $19.00 (53.8% upside) with 14 buy ratings. Key risks include mixed earnings performance, high debt levels despite recent reduction, and leadership transition. The stock offers potential for re-rating if management delivers on margin expansion and growth targets outlined in recent investor presentations.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
EWS tracks the MSCI Singapore 25/50 Index, providing targeted exposure to large and mid-cap companies in Singapore. It is heavily weighted toward the financial, industrial, and real estate sectors, serving as a liquid tool for accessing Singapore's stable, dividend-oriented developed economy.
Read more on EWS →Herbalife Nutrition Ltd is an international nutrition company.
Read more on HLF →